Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

Abstract Background Breast cancers with 1–10% cell staining for estrogen receptor (ER) present particular clinical features. The clinical data of estrogen receptor expression level and treatment effect are limited, particularly regarding chemotherapy benefit. We evaluated the pathologic response to...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Hai-long Chen, Feng-bo Huang, Qiang Chen, Yong-chuan Deng
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	BMC 2023-09-01
Loạt:	BMC Cancer
Những chủ đề:	Breast cancer Estrogen receptor Neoadjuvant chemotherapy Pathologic complete response Prognosis
Truy cập trực tuyến:	https://doi.org/10.1186/s12885-023-11368-2

Những quyển sách tương tự

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
Bằng: He Dou, et al.
Được phát hành: (2024-01-01)

Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
Bằng: I.P.C. Buzatto, et al.

Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy
Bằng: Yingbo Shao, et al.
Được phát hành: (2025-03-01)

Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy
Bằng: Yingbo Shao, et al.
Được phát hành: (2024-02-01)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
Bằng: Jin Hong, et al.
Được phát hành: (2021-11-01)

Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study
Bằng: Lingfeng Tang, et al.
Được phát hành: (2024-05-01)

A real-world clinicopathological model for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer
Bằng: Shan Fang, et al.
Được phát hành: (2024-02-01)

Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy
Bằng: Zhendong Shi, et al.
Được phát hành: (2024-07-01)

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
Bằng: Yoshitaka Shimamaki, et al.
Được phát hành: (2024-02-01)

Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
Bằng: Mengping Long, et al.
Được phát hành: (2022-12-01)

Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
Bằng: Elina Sivina, et al.
Được phát hành: (2023-03-01)

Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer
Bằng: Shuling Zhou, et al.
Được phát hành: (2023-02-01)

Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers
Bằng: Ling-Ming Tseng, et al.
Được phát hành: (2023-12-01)

Metabolic syndrome is a risk factor for breast cancer patients receiving neoadjuvant chemotherapy: A case-control study
Bằng: Zhaoyue Zhou, et al.
Được phát hành: (2023-01-01)

The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery
Bằng: Mina M. G. Youssef, et al.
Được phát hành: (2021-02-01)

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis
Bằng: Yue Guo, et al.
Được phát hành: (2025-02-01)

Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy
Bằng: Cui Jiang, et al.
Được phát hành: (2019-09-01)

Factors predicting pathological complete response to neoadjuvant chemotherapy in patients diagnosed with non-metastatic muscle invasive urothelial bladder cancer
Bằng: Zuhat Urakçı, et al.
Được phát hành: (2023-10-01)

PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning
Bằng: Witali Aswolinskiy, et al.
Được phát hành: (2023-11-01)

Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy
Bằng: Li-Yun Xie, et al.
Được phát hành: (2022-04-01)

Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study
Bằng: Lingfeng Tang, et al.
Được phát hành: (2022-12-01)

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival
Bằng: Ruo-Xi Wang, et al.
Được phát hành: (2022-10-01)

Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-Analysis
Bằng: Samuel Rosner, MD, et al.
Được phát hành: (2022-09-01)

Imaging‐proteomic analysis for prediction of neoadjuvant chemotherapy responses in patients with breast cancer
Bằng: Jingxian Duan, et al.
Được phát hành: (2023-12-01)

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP
Bằng: Jung Hwan Ji, et al.
Được phát hành: (2023-01-01)

Neoadjuvant chemotherapy efficacy and prognosis in HER2-low and HER2-zero breast cancer patients by HR status: a retrospective study in China
Bằng: Shaorong Zhao, et al.
Được phát hành: (2024-05-01)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
Bằng: Pingping Liu, et al.
Được phát hành: (2022-04-01)

Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response
Bằng: P. V. Krivorotko, et al.
Được phát hành: (2022-12-01)

Response rate and clinical outcome of HER2-low breast cancer after neoadjuvant therapy: a single-center retrospective study
Bằng: WANG Ruoxi, JI Peng, GONG Yue, CHEN Sheng
Được phát hành: (2023-07-01)

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
Bằng: Yanhua Chen, et al.
Được phát hành: (2020-03-01)

Estrogen Receptor and Claudin-6 Might Play Vital Roles for Long-Term Prognosis in Patients With Luminal A Breast Cancer Who Underwent Neoadjuvant Chemotherapy
Bằng: Yushi Liu, et al.
Được phát hành: (2022-06-01)

A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)
Bằng: Amina Maimaitiaili, et al.
Được phát hành: (2024-05-01)

Construction of a nomogram prediction model for the pathological complete response after neoadjuvant chemotherapy in breast cancer: a study based on ultrasound and clinicopathological features
Bằng: Pingjuan Ni, et al.
Được phát hành: (2025-03-01)

Optimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights
Bằng: Lucas MW, et al.
Được phát hành: (2022-08-01)

Predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients based on ultrasound longitudinal temporal depth network fusion model
Bằng: Xiaodan Feng, et al.
Được phát hành: (2025-02-01)

The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy
Bằng: Sedat Yildirim, et al.
Được phát hành: (2024-05-01)

Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma
Bằng: Yiling Wang, et al.
Được phát hành: (2022-03-01)

The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis
Bằng: Eva L. Claassens, et al.
Được phát hành: (2025-04-01)

Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis
Bằng: Yonghe Chen, et al.
Được phát hành: (2025-01-01)

Radiomic model based on magnetic resonance imaging for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Bằng: Yimiao Yu, et al.
Được phát hành: (2024-01-01)